Literature DB >> 33970417

Relationship between hyperuricemia and serositis in patients with lupus nephritis.

Ping Nie1, Liangqian Hu2, Bing Li1, Yan Lou1, Manyu Luo1, Yali Wang1, Xuehong Lu3, Ping Luo4.   

Abstract

PURPOSE: To investigate the clinical and pathological characteristics of lupus nephritis (LN) patients with serositis and analyse the relationship between serositis and hyperuricemia (HUA) in LN patients in northeast China.
METHODS: The data of patients with LN diagnosed by renal biopsy in our hospital from April 2013 to May 2020 were retrospectively analyzed. The differences between the non-serositis and serositis groups were compared by t tests and Chi-square test. Factors with P < 0.05 in the univariate analyses were investigated further using binary logistic regression analysis to investigate the independent risk factors of serositis in patients with LN.
RESULTS: LN patients with serositis were more likely to have fever, hypertension, neuropsychiatric and hematological involvement than those without serositis (P < 0.05). Compared with the non-serositis group, LN patients with serositis were prone to have HUA, high D-dimer, high triglycerides, and had significant differences in the levels of plasma albumin (Alb), estimated glomerular filtration rate (eGFR), erythrocyte sedimentation rate, C-reactive protein, complement C3, 24-h urinary protein, pathological types, pathological score and SLEDAI score. Logistic regression analysis showed that HUA was one of risk factors for serositis in LN patients. The rate of complete remission in LN patients with serositis was significantly lower (P < 0.05) and the rate of no remission and mortality were significantly higher (P < 0.05) than LN patients without serositis.
CONCLUSION: LN patients with serositis had more severe clinical and pathological manifestations, higher systemic lupus erythematosus (SLE) activity and worse prognosis. Hyperuricemia is associated with serositis in LN patients.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Complement C3; Hyperuricemia; Lupus nephritis; Serositis

Mesh:

Year:  2021        PMID: 33970417     DOI: 10.1007/s11255-021-02873-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  33 in total

1.  Relation between serum uric acid levels with the degree of coronary artery disease: A prospective study from Ecuador.

Authors:  Maria Egas-Izquierdo; Xavier Wong-Achi; Geovanny Alvarado-Villa; Hans Mautong
Journal:  Clin Investig Arterioscler       Date:  2018-10-31

2.  Uric acid and chronic kidney disease: A time to act?

Authors:  Gianni Bellomo
Journal:  World J Nephrol       Date:  2013-05-06

Review 3.  Lupus nephritis: an update.

Authors:  Tasnim F Imran; Frederick Yick; Suneet Verma; Christopher Estiverne; Chinonye Ogbonnaya-Odor; Srikanth Thiruvarudsothy; Alluru S Reddi; Neil Kothari
Journal:  Clin Exp Nephrol       Date:  2015-10-16       Impact factor: 2.801

4.  The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study.

Authors:  Yan Liang; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2016-12-20       Impact factor: 2.631

5.  Hypertension as Determinant of Hyperuricemia: A Case Control Study from the Sub-Himalayan Region in North India.

Authors:  Sujeet Raina; Vishnu Kumar Agarwal; Dhiraj Kapoor; Kailash Nath Sharma; R S Yadav
Journal:  J Assoc Physicians India       Date:  2018-01

6.  Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus.

Authors:  J Zhao; W Bai; P Zhu; X Zhang; S Liu; L Wu; L Ma; L Bi; X Zuo; L Sun; C Huang; X Tian; M Li; Y Zhao; X Zeng
Journal:  Lupus       Date:  2016-01-12       Impact factor: 2.911

7.  High serum uric acid levels are a protective factor against unfavourable neurological functional outcome in patients with ischaemic stroke.

Authors:  Yu-Fang Wang; Jiao-Xing Li; Xun-Sha Sun; Rong Lai; Wen-Li Sheng
Journal:  J Int Med Res       Date:  2018-03-12       Impact factor: 1.671

8.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

9.  Effects of Body Mass Index, Glycemic Control, and Hypoglycemic Drugs on Serum Uric Acid Levels in Type 2 Diabetic Patients.

Authors:  Azhar Hussain; Omar B Latiwesh; Farwa Ali; Mustafa Y G Younis; Jamal A Alammari
Journal:  Cureus       Date:  2018-08-17

10.  Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults.

Authors:  Nurshad Ali; Rasheda Perveen; Shahnaz Rahman; Shakil Mahmood; Sadaqur Rahman; Shiful Islam; Tangigul Haque; Abu Hasan Sumon; Rahanuma Raihanu Kathak; Noyan Hossain Molla; Farjana Islam; Nayan Chandra Mohanto; Shaikh Mirja Nurunnabi; Shamim Ahmed; Mustafizur Rahman
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.